TCL Archive In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research January 16, 1976
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive September issue of Business & Regulatory Report included–8 additional pages of industry news. October 1, 2004
